Jane Street Group LLC Sells 2,752 Shares of Utah Medical Products, Inc. (NASDAQ:UTMD)

Jane Street Group LLC trimmed its stake in shares of Utah Medical Products, Inc. (NASDAQ:UTMD) by 46.8% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 3,127 shares of the medical instruments supplier’s stock after selling 2,752 shares during the quarter. Jane Street Group LLC owned approximately 0.09% of Utah Medical Products worth $209,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently made changes to their positions in UTMD. Minerva Advisors LLC increased its position in Utah Medical Products by 461.8% during the 3rd quarter. Minerva Advisors LLC now owns 42,328 shares of the medical instruments supplier’s stock valued at $2,818,000 after purchasing an additional 34,794 shares during the period. State Street Corp boosted its stake in shares of Utah Medical Products by 0.9% in the 3rd quarter. State Street Corp now owns 80,856 shares of the medical instruments supplier’s stock valued at $5,434,000 after purchasing an additional 694 shares during the last quarter. Brandes Investment Partners LP increased its position in shares of Utah Medical Products by 66.2% during the second quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock worth $7,789,000 after buying an additional 46,427 shares during the period. BNP Paribas Financial Markets increased its position in shares of Utah Medical Products by 102.7% during the third quarter. BNP Paribas Financial Markets now owns 1,117 shares of the medical instruments supplier’s stock worth $75,000 after buying an additional 566 shares during the period. Finally, Sanctuary Advisors LLC bought a new position in Utah Medical Products during the second quarter worth $413,000. 69.60% of the stock is owned by institutional investors and hedge funds.

Utah Medical Products Price Performance

NASDAQ UTMD opened at $60.91 on Monday. The stock has a market capitalization of $206.61 million, a P/E ratio of 14.26 and a beta of 0.09. The business has a 50 day simple moving average of $63.74 and a 200 day simple moving average of $65.95. Utah Medical Products, Inc. has a one year low of $60.17 and a one year high of $84.99.

Utah Medical Products Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 3rd. Stockholders of record on Monday, December 16th were given a dividend of $0.305 per share. This is an increase from Utah Medical Products’s previous quarterly dividend of $0.30. The ex-dividend date was Monday, December 16th. This represents a $1.22 annualized dividend and a dividend yield of 2.00%. Utah Medical Products’s dividend payout ratio (DPR) is 28.57%.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded Utah Medical Products from a “strong-buy” rating to a “buy” rating in a report on Thursday, November 7th.

Utah Medical Products Company Profile

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.